MAIA Biotechnology, Inc. announced a private placement of a warrant to purchase up to 239,234 shares of common stock at an exercise price of $2.09 per warrant for the gross proceeds of $499,999.06 on November 9, 2023. The transaction included participation from new investor Alumni Capital LP. The Warrant is exercisable beginning on November 10, 2023, has a term of four years from the initial exercise date.

The holder of the warrant may from time to time prior to November 30, 2023 agree to acquire, and the company may agree to sell to such holder, up to an aggregate of $500,000 of Common Stock in issuances registered under the Securities Act of 1933, as amended.